Hospital costs for treating newborns in opioid withdrawal jumps
The cost of treatment for infants in US hospitals who had been exposed to opioids rose by more than $250 million over four years, according to a study published Monday.
prescription drug abuse
Sackler family withdrew more than $10 billion from Purdue Pharma
Members of the Sackler family withdrew more than $10 billion from Purdue Pharma and put the money in family trusts and holding companies as pressure intensified over the nation's opioid epidemic, according to court documents.
FDA issues warning for products marketed to treat opioid withdrawal
The FDA sent a warning letter to EPH Technologies, accusing it of marketing and selling unapproved drugs.
Middle-aged black adults see rise in opioid deaths
About 48,000 people lost their lives to opioids in 2017, the latest year for which complete data is available, according to a new study. Synthetic opioids, such as fentanyl, accounted for almost two-thirds of those deaths.
Benzos: Another prescription drug with deadly consequences
The opioid epidemic has gotten a lot of attention, and rightfully so, but another kind of prescription drug also has deadly consequences, especially when combined with opioids.
Fentanyl deadliest drug in US, but meth kills more in some places
Fentanyl remains the deadliest drug in the United States, but in some areas of the country, methamphetamine kills more people.
Melania Trump receives warm welcome on first solo Capitol Hill visit
President Donald Trump is a lightning rod on Capitol Hill, but his wife, however, apparently is not.
4 drug companies reach $235M settlement ahead of trial
Hours before the first federal trial in the opioid epidemic was set to begin, four pharmaceutical companies reached a settlement totaling $260 million.
Drug companies fail to reach settlement ahead of opioid crisis trial
Six drug companies accused in thousands of lawsuits over their role in the nation's opioid epidemic failed to reach a settlement with governments across the country, setting the stage for a high-profile trial Monday.
Drug companies may pay $50 billion for their role in opioid crisis
Five of the many companies accused in thousands of federal and state lawsuits over the nation's opioid epidemic may settle for over $50 billion, according to a source familiar with the negotiations.
